PROPUBLICA Expose Corruption. Defend Truth. Support Investigative Journalism.
DONATE
Skip to content
ProPublica Donate
ProPublica Donate

International Aids Vaccine Initiative Inc

Dba Aids Vaccine Initiative Intl

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: International, Foreign Affairs and National Security / International Development, Relief Services (NTEE)

Donations to this organization are tax deductible.

Details

According to its Dec. 2023 tax filing, this nonprofit:

Reported conflict of interest transactions
Organizations must report loans, grants or business transactions with interested parties, which may include key employees and officers, their family members and any businesses in which they hold a controlling interest. These transactions must be reported on Schedule L.

Summary charts: organization finances over time

Revenue
$130M (2023)

20112023 $0$50M$100M$150M

Expenses
$133M (2023)

20112023 $0$50M$100M$150M

Total Assets
$124M (2023)

20112023 $0$50M$100M$150M

Total Liabilities
$60.3M (2023)

20112023 $0$20M$40M$60M$80M
Source: Form 990 tax filings from 2011 to 2023

Tax Filings and Audits by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Audits are required to be submitted by nonprofit organizations that spend $750,000 or more in federal grant money in a fiscal year. "Single audits" look at the entire organization's finances and compliance, while other audits are program specific. Nonprofit Explorer has PDFs of audits for some nonprofits for fiscal year 2015 and later. Audit data is from the Federal Audit Clearinghouse.

Fiscal Year Ending Dec.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$129,678,400
Expenses
$132,896,237
Net Income
-$3,217,837
Net Assets
$63,923,752
Notable Sources of Revenue Percent of Total Revenue
Contributions $124,587,673
96.1%
Program Services $2,297,276
1.8%
Investment Income $3,256,766
2.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$494,343
Net Inventory Sales $0
Other Revenue $31,028
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,429,430
1.8%
Professional Fundraising Fees $0
Other Salaries and Wages $36,453,779
27.4%
Assets/Debt
Total Assets $124,233,943
Total Liabilities $60,310,191
Net Assets $63,923,752
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark B Feinberg (President/Ceo) $719,151 $0 $110,715
Ana Cespedes Montoya (Chief Operating Officer) $531,087 $0 $79,268
Dagna Laufer (Vp & Head Of Clinical Dev.) $394,188 $0 $41,148
Louis D Schwartz (Asst. Sec. & Cfao) $390,586 $0 $76,520
Swati Gupta (Vp, Head Of Eid & Epidem.) $379,201 $0 $76,490
Sangeetha Sagar (Vp & Head Of Product Dev) $376,047 $0 $33,504
Christopher Parks Assoc (Avp. Viral Vac. & Head Of Ddl) $365,204 $0 $62,119
Eric Skjeveland (Vp, Business Development) $341,395 $0 $36,715
Min Ding (Gen. Couns. & Sec.) $333,986 $0 $71,843
Frances Sinha (Former Officer) $105,000 $0 $0
Mario Gagliano (Cpo, Vp Of Hr (From 9/23)) $102,045 $0 $14,230
Eric Paul Goosby (Board Chair) $0 $0 $0
Robert Goldberg (Board Treasurer) $0 $0 $0
Linda Gail Becker (Board Member) $0 $0 $0
David Blumberg (Board Member) $0 $0 $0
Jim Connolly (Board Member) $0 $0 $0
Mark Dybul (Board Member) $0 $0 $0
Wafaa El Sadr (Board Member) $0 $0 $0
Alexis M Pinto (Board Member) $0 $0 $0
John W Shiver (Board Member) $0 $0 $0
Susan Silbermann (Board Member) $0 $0 $0
Anne Martin Simonds (Board Member) $0 $0 $0
Rajeev Venkayya (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$146,782,280
Expenses
$131,188,762
Net Income
$15,593,518
Net Assets
$66,267,054
Notable Sources of Revenue Percent of Total Revenue
Contributions $143,987,755
98.1%
Program Services $2,569,928
1.8%
Investment Income $751,530
0.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$930,344
Net Inventory Sales $0
Other Revenue $403,411
0.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,614,665
2.0%
Professional Fundraising Fees $0
Other Salaries and Wages $33,612,789
25.6%
Assets/Debt
Total Assets $128,948,484
Total Liabilities $62,681,430
Net Assets $66,267,054
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark B Feinberg (President/Ceo) $666,687 $0 $96,566
Ana Cespedes Montoya (Chief Operating Officer) $510,065 $0 $109,309
Dagna Laufer (Vp & Head Of Clinical Development) $377,615 $0 $43,357
Swati Gupta (Vp, Head Of Eid & Epidemiology) $364,496 $0 $86,183
Louis D Schwartz (Asst. Sec. & Chief Financial Officer) $363,556 $0 $85,739
Thomas Hassell (Vp, Pdc (Until 9/30/22)) $353,175 $0 $75,197
Frances Sinha (Cpo, Vp Of Hr (Until 12/1/22)) $345,114 $0 $44,733
Christopher Parks Assoc (Vp, Viral Vaccines & Head Of The Ddl) $340,566 $0 $70,686
Min Ding (Gen. Couns. & Sec. (From 3/14/22)) $325,059 $0 $67,838
Eric Skjeveland (Vp, Business Development) $314,481 $0 $17,149
Eric Paul Goosby (Board Chair) $0 $0 $0
Robert Goldberg (Board Treasurer) $0 $0 $0
Linda Gail Becker (Board Member) $0 $0 $0
David Blumberg (Board Member) $0 $0 $0
Jim Connolly (Board Member) $0 $0 $0
Mark Dybul (Board Member) $0 $0 $0
Wafaa El Sadr (Board Member) $0 $0 $0
John Nkengasong (Board Member (Until 5/16/22)) $0 $0 $0
Alexis M Pinto (Board Member) $0 $0 $0
John W Shiver (Board Member) $0 $0 $0
Susan Silbermann (Board Member) $0 $0 $0
Anne Martin Simonds (Board Member) $0 $0 $0
Rajeev Venkayya (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$126,352,598
Expenses
$113,151,683
Net Income
$13,200,915
Net Assets
$50,970,295
Notable Sources of Revenue Percent of Total Revenue
Contributions $124,414,676
98.5%
Program Services $1,706,926
1.4%
Investment Income $613,689
0.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$553,801
Net Inventory Sales $0
Other Revenue $171,108
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,402,142
2.1%
Professional Fundraising Fees $0
Other Salaries and Wages $30,069,602
26.6%
Assets/Debt
Total Assets $107,049,023
Total Liabilities $56,078,728
Net Assets $50,970,295
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark Feinberg (President/Ceo) $646,997 $0 $36,716
Ana Cespedes Montoya (Chief Operating Officer) $509,916 $0 $64,942
Christopher Parks (Executive Dir., Viral Vaccinces) $464,753 $0 $62,532
Swati Gupta (Vp, Eid & Scientific Strategy) $435,928 $0 $77,476
Thomas Hassell (Vp, Vaccine Development R&D) $396,671 $0 $65,639
Louis Schwartz (Asst. Sec. & Chief Financial Officer) $368,299 $0 $65,639
William Ballou (Adv Sr Sci Adv/Proj Lead, Hiv Bnabs) $362,316 $0 $46,801
Dagna Laufer (Vp & Head Of Clinical Development) $356,214 $0 $32,479
Frances Sinha (Chief People Officer) $343,388 $0 $45,818
Labeeb Abboud (Sec. Sr Vp, Gen Couns (Until 7/31/21)) $276,345 $0 $44,080
Eric Paul Goosby (Board Chair) $0 $0 $0
Anne M Vanlent (Board Vice Chair (Until 12/2/21)) $0 $0 $0
Robert Goldberg (Board Treasurer) $0 $0 $0
Linda Gail Becker (Board Member) $0 $0 $0
David Blumberg (Board Member) $0 $0 $0
Jim Connolly (Board Member) $0 $0 $0
Mark Dybul (Board Member) $0 $0 $0
Wafaa El Sadr (Board Member (From 12/1/21)) $0 $0 $0
Francine Ntoumi (Board Member (Until 12/2/21)) $0 $0 $0
John Nkengasong (Board Member) $0 $0 $0
Alexis M Pinto (Board Member (From 12/1/21)) $0 $0 $0
John W Shiver (Board Member) $0 $0 $0
Susan Silbermann (Board Member (From 12/1/21)) $0 $0 $0
Anne Martin Simonds (Board Member) $0 $0 $0
Rajeev Venkayya (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$97,111,665
Expenses
$96,068,184
Net Income
$1,043,481
Net Assets
$39,251,040
Notable Sources of Revenue Percent of Total Revenue
Contributions $88,668,597
91.3%
Program Services $7,491,603
7.7%
Investment Income $741,488
0.8%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$16,196
Net Inventory Sales $0
Other Revenue $226,173
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,414,937
2.5%
Professional Fundraising Fees $0
Other Salaries and Wages $27,234,003
28.3%
Assets/Debt
Total Assets $81,721,759
Total Liabilities $42,470,719
Net Assets $39,251,040
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark Feinberg (President/Ceo) $614,092 $0 $35,461
Ana Cespedes Montoya (Chief Operating Officer) $480,579 $0 $70,132
Labeeb Abboud (Secretary, Sr Vp, General Counsel) $400,266 $0 $70,132
Thomas Hassell (Vp Vaccine Development R&D) $361,421 $0 $70,132
Louis Schwartz (Asst. Sec. & Chief Financial Officer) $340,501 $0 $70,132
Swati Gupta (V.P. Eid & Scientific Strategy) $327,291 $0 $66,707
Dagna Laufer (Vp & Head Of Clinical Development) $326,220 $0 $31,779
Christopher Parks (Executive Dir., Viral Vaccines) $313,153 $0 $54,962
Margaret Keane (Vp Global All. & Prod. Opt) $309,908 $0 $45,294
Frances Sinha (Chief People Officer) $280,711 $0 $52,931
Eric Paul Goosby (Board Chair) $0 $0 $0
Anne M Vanlent (Board Vice Chair) $0 $0 $0
Robert Goldberg (Board Treasurer) $0 $0 $0
Linda Gail Becker (Board Member) $0 $0 $0
David Blumberg (Board Member) $0 $0 $0
Jim Connolly (Board Member) $0 $0 $0
Hon Mark Dybul (Board Member) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0
John Nkengasong (Board Member) $0 $0 $0
Francine Ntoumi (Board Member) $0 $0 $0
John W Shiver (Board Member) $0 $0 $0
Anne Martin Simonds (Board Member) $0 $0 $0
Rajeev Venkayya (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$88,458,944
Expenses
$87,783,507
Net Income
$675,437
Net Assets
$37,656,524
Notable Sources of Revenue Percent of Total Revenue
Contributions $85,441,168
96.6%
Program Services $421,890
0.5%
Investment Income $1,171,355
1.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $216,653
0.2%
Net Inventory Sales $0
Other Revenue $1,207,878
1.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,057,702
2.3%
Professional Fundraising Fees $0
Other Salaries and Wages $23,772,041
27.1%
Assets/Debt
Total Assets $74,755,062
Total Liabilities $37,098,538
Net Assets $37,656,524
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark Feinberg (President/Ceo) $555,341 $0 $31,311
Ana Cespedes Montoya (Chief Operating Officer) $424,619 $0 $72,649
Labeeb Abboud (Secretary, Sr Vp, General Counsel) $375,304 $0 $62,520
Thomas Hassell (Vp Vaccine Development R&D) $333,344 $0 $63,706
Ann Ginsberg (Senior Technical Advisor) $324,265 $0 $30,800
Christopher Parks (Executive Dir., Viral Vaccines) $314,499 $0 $57,420
Louis Schwartz (Asst. Sec. & Chief Financial Officer) $309,837 $0 $63,706
Swati Gupta (Vp Research Integration & Innovation) $302,410 $0 $70,458
Margaret Keane (Vp Global All. & Prod. Optimization) $290,912 $0 $30,005
Frances Sinha (Chief People Officer (Beg. 04/19)) $150,884 $0 $11,531
Eric Paul Goosby (Board Chair) $0 $0 $0
Anne M Vanlent (Board Vice Chair) $0 $0 $0
Robert Goldberg (Board Treasurer) $0 $0 $0
Francine Ntoumi (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0
Rajeev Venkayya (Board Member) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0
Jim Connolly (Board Member) $0 $0 $0
Linda Gail Becker (Board Member) $0 $0 $0
Hon Mark Dybul (Board Member) $0 $0 $0
David Blumberg (Board Member) $0 $0 $0
John W Shiver (Board Member) $0 $0 $0
Anne Martin Simonds (Board Member) $0 $0 $0
John Nkengasong (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$77,192,773
Expenses
$83,383,050
Net Income
-$6,190,277
Net Assets
$37,181,724
Notable Sources of Revenue Percent of Total Revenue
Contributions $75,524,844
97.8%
Program Services $396,577
0.5%
Investment Income $921,661
1.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $349,691
0.5%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,838,872
2.2%
Professional Fundraising Fees $0
Other Salaries and Wages $22,497,547
27.0%
Assets/Debt
Total Assets $83,382,669
Total Liabilities $46,200,945
Net Assets $37,181,724
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark Feinberg (President/Ceo) $553,503 $0 $30,769
Labeeb Abboud (Secretary, Sr Vp, General Counsel) $378,295 $0 $59,950
Thomas Hassell (V.P. Vaccine Development R&D) $345,158 $0 $59,950
Louis Schwartz (Chief Financial Officer) $324,722 $0 $59,950
Swati Gupta (V.P. Research Integration & Innov.) $319,471 $0 $57,395
Christopher Parks (Executive Dir., Viral Vaccines) $313,102 $0 $59,950
Margaret T Keane (V.P. Global All. & Product) $311,679 $0 $48,777
Frances Priddy (Executive Dir, Chief Medical Officer) $299,146 $0 $59,950
Anthony Musyoka (H.R., Asst. Secretary (Until 8/18)) $244,969 $0 $49,551
Ana Cespedes Montoya (Chief Operating Officer (From 9/18)) $113,846 $0 $23,307
Eric Paul Goosby (Board Chair) $0 $0 $0
Anne M Vanlent (Board Vice Chair) $0 $0 $0
Robert Goldberg (Board Treasurer) $0 $0 $0
Francine Ntoumi (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0
Rajeev Venkayya (Board Member (From 12/18)) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0
Jim Connolly (Board Member (From 12/18)) $0 $0 $0
Linda Gail Becker (Board Member (From 1/18)) $0 $0 $0
Christina Hull Paxson (Board Member (From 1/18, Until 6/18)) $0 $0 $0
Mark Dybul (Board Member (From 3/18)) $0 $0 $0
Moncef Slaoui (Board Member (Until 3/18)) $0 $0 $0
David Blumberg (Board Member (From 12/18)) $0 $0 $0
John W Shiver (Board Member (From 7/18)) $0 $0 $0
Anne Martin Simonds (Board Member (From 10/18)) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$80,526,964
Expenses
$85,397,465
Net Income
-$4,870,501
Net Assets
$43,915,285
Notable Sources of Revenue Percent of Total Revenue
Contributions $79,435,403
98.6%
Program Services $260,438
0.3%
Investment Income $596,174
0.7%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $234,949
0.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,716,314
2.0%
Professional Fundraising Fees $0
Other Salaries and Wages $20,146,708
23.6%
Assets/Debt
Total Assets $81,959,513
Total Liabilities $38,044,228
Net Assets $43,915,285
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark Feinberg (President/Ceo) $545,949 $0 $34,287
Labeeb Abboud (Secretary, Sr Vp, General Counsel) $365,455 $0 $55,357
Thomas Hassell (V.P. Vaccine Development R&D) $345,576 $0 $55,357
Christopher Parks (Executive Dir., Viral Vaccines) $331,786 $0 $52,106
Louis Schwartz (Chief Financial Officer) $308,531 $0 $55,357
Fran Priddy (Executive Dir., Chief Medical Off.) $297,292 $0 $29,700
Anthony Musyoka (Human Resources, Asst. Secretary) $296,021 $0 $55,357
Antu Dey (Snr. Dir., Hiv Envelope Immun. Dev'l) $288,448 $0 $55,398
Margaret T Keane (V.P. Global All. & Product Opt.) $259,501 $0 $33,413
Eric Paul Goosby (Board Chair) $0 $0 $0
Anne M Vanlent (Board Vice Chair & Treasurer) $0 $0 $0
Robert Goldberg (Board Member) $0 $0 $0
Adel Af Mahoud (Board Member) $0 $0 $0
Francine Ntoumi (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0
Moncef Slaoui (Board Member) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$65,023,177
Expenses
$73,947,939
Net Income
-$8,924,762
Net Assets
$47,062,754
Notable Sources of Revenue Percent of Total Revenue
Contributions $63,919,808
98.3%
Program Services $0
Investment Income $538,881
0.8%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $447,590
0.7%
Net Inventory Sales $0
Other Revenue $116,898
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,606,381
2.2%
Professional Fundraising Fees $0
Other Salaries and Wages $19,011,060
25.7%
Assets/Debt
Total Assets $89,152,233
Total Liabilities $42,089,479
Net Assets $47,062,754
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Mark Feinberg (President/Ceo) $466,174 $0 $33,741
Labeeb Abboud (Secretary/Sr Vp, General Counsel) $354,986 $0 $52,467
Thomas Hassell (V.P. Vaccine Development R&D) $347,342 $0 $52,467
Louis Schwartz (Chief Financial Officer) $297,158 $0 $52,467
Christopher Parks (Exec Dir., Viral Vaccines) $291,557 $0 $50,528
Anthony Musyoka (V.P. Human Resources, Assit. Secretary) $286,121 $0 $52,467
Frances Priddy (Exec Dir., Chief Medical Officer) $284,916 $0 $29,000
Dagna Laufer (Snr. Dir., Medical Affairs) $251,275 $0 $24,209
Eddy Sayeed (Snr. Dir., Process Development & Manufacturing) $235,742 $0 $54,642
Robin Weiss See Sch O (Board Member (Until 6/7/16)) $10,800 $0 $0
Eric Paul Goosby (Board Chair (As Of 6/7/16)) $0 $0 $0
Alex Godwin Coutinho (Board Chair (Until 6/7/16)) $0 $0 $0
Anne M Vanlent (Board Vice Chair & Treasurer) $0 $0 $0
Adel Af Mahmoud (Board Member) $0 $0 $0
Francine Ntoumi (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0
Moncef Slaoui (Board Member) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0
Robert Goldberg (Board Member (Began 11/29/16)) $0 $0 $0
Mary C Tydings (Board Member (Until 11/30/16)) $0 $0 $0
The Rt Hon The Lord Fowler (Board Member (Until 6/21/16)) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$72,394,949
Expenses
$67,690,431
Net Income
$4,704,518
Net Assets
$56,904,349
Notable Sources of Revenue Percent of Total Revenue
Contributions $71,447,864
98.7%
Program Services $530,970
0.7%
Investment Income $694,495
1.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$783,455
Net Inventory Sales $0
Other Revenue $505,075
0.7%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,375,518
2.0%
Professional Fundraising Fees $0
Other Salaries and Wages $18,133,989
26.8%
Assets/Debt
Total Assets $85,094,617
Total Liabilities $28,190,268
Net Assets $56,904,349
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Wayne Koff (Chief Scientific Officer/Sr Vp R&D) $434,601 $0 $59,006
Margaret Mcglynn (President/Ceo (Until 9/8/15)) $370,713 $0 $42,359
Labeeb Abboud (Secretary/Sr Vp, General Counsel) $352,039 $0 $50,793
Thomas Hassell (V.P. Vaccine Development R&D) $348,872 $0 $50,793
Louis Schwartz (Chief Financial Officer) $303,964 $0 $50,793
Christopher Parks (Exec Dir., Viral Vaccines) $289,644 $0 $49,740
Anthony Musyoka (V.P. Human Resources) $286,980 $0 $50,793
Frances Priddy (Exec Dir., Chief Medical Officer) $283,966 $0 $28,200
Mark Feinberg (President/Ceo (Began 9/8/15)) $170,714 $0 $1,742
Robin Weiss See Sch O (Board Member) $32,400 $0 $0
Alex Godwin Coutinho (Board Chair) $0 $0 $0
Anne M Vanlent (Treasurer) $0 $0 $0
Adel Af Mahmoud (Board Member) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0
Helen Rees (Board Member (Until 3/18/15)) $0 $0 $0
Mary C Tydings (Board Member) $0 $0 $0
Moncef Slaoui (Board Member) $0 $0 $0
Lord Fowler (Board Member) $0 $0 $0
Eric Paul Goosby (Board Member) $0 $0 $0
Francine Ntoumi (Board Member (Began 6/9/15)) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$52,466,584
Expenses
$59,988,992
Net Income
-$7,522,408
Net Assets
$52,709,791
Notable Sources of Revenue Percent of Total Revenue
Contributions $50,593,210
96.4%
Program Services $511,142
1.0%
Investment Income $775,037
1.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $587,195
1.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,244,318
2.1%
Professional Fundraising Fees $0
Other Salaries and Wages $16,626,809
27.7%
Assets/Debt
Total Assets $92,681,919
Total Liabilities $39,972,128
Net Assets $52,709,791
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Margaret Mcglynn (President/Ceo) $508,359 $0 $37,264
Wayne Koff (Chief Scientific Officer/Sr Vp R&D) $374,703 $0 $48,753
Thomas Hassell (V.P. Vaccine Development R&D) $312,946 $0 $47,335
Labeeb Abboud (Secretary/Sr Vp, General Counsel) $309,269 $0 $47,917
Christopher Parks (Exec Dir., Viral Vaccines) $274,742 $0 $42,085
Frances Priddy (Exec Dir., Chief Medical Officer) $273,197 $0 $27,382
Louis Schwartz (Chief Financial Officer) $269,259 $0 $47,052
Anthony Musyoka (V.P. Human Resources) $255,068 $0 $45,924
Robin Weiss See Sch O (Board Member) $25,200 $0 $0
Alex Godwin Coutinho (Board Chair) $0 $0 $0
Anne M Vanlent (Treasurer) $0 $0 $0
Paul H Klingenstein (Board Member (Until 12/05/2014)) $0 $0 $0
Geoffrey Lamb (Board Member (Until 12/05/2014)) $0 $0 $0
Adel Af Mahmoud (Board Member) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0
Marijke Wijnroks (Board Member) $0 $0 $0
Helen Rees (Board Member) $0 $0 $0
Mary C Tydings (Board Member) $0 $0 $0
Moncef Slaoui (Board Member) $0 $0 $0
Lord Fowler (Board Member) $0 $0 $0
Eric Paul Goosby (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$66,366,876
Expenses
$58,739,167
Net Income
$7,627,709
Net Assets
$75,804,185
Notable Sources of Revenue Percent of Total Revenue
Contributions $63,996,178
96.4%
Program Services $0
Investment Income $1,225,832
1.8%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $114,650
0.2%
Net Inventory Sales $0
Other Revenue $1,030,216
1.6%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,257,461
2.1%
Professional Fundraising Fees $0
Other Salaries and Wages $15,764,006
26.8%
Assets/Debt
Total Assets $105,112,068
Total Liabilities $29,307,883
Net Assets $75,804,185
Compensation
Key Employees and Officers Compensation Related Other
Margaret Mcglynn (President/Ceo) $503,191 $0 $28,000
Wayne Koff (Chief Scientific Officer/Sr. Vp R&D) $359,331 $0 $47,056
Thomas Hassell (V.P. Vaccine Development R&D) $303,227 $0 $44,920
Christopher Parks (Exec Dir., Viral Vaccines) $290,205 $0 $39,495
Charles R King (V.P. Vaccine Design R&D) $288,907 $0 $28,335
Labeeb Abboud (Senior Vp, General Counsel) $260,752 $0 $43,597
Derek Hodkey (Exec Dir., R&D Operations) $252,700 $0 $42,163
Louis Schwartz (Chief Financial Officer) $244,557 $0 $45,358
Reinhard Kurth See Sch O (Board Member (Until 6/27/13)) $20,400 $0 $0
Robin Weiss See Sch O (Board Member) $9,568 $0 $0
Paul H Klingenstein (Chair) $0 $0 $0
Ian Gust (Secretary (Until 12/6/13)) $0 $0 $0
Anne M Vanlent (Treasurer) $0 $0 $0
Alex Godwin Coutinho (Board Member) $0 $0 $0
John D Evans (Board Member (Until 12/6/13)) $0 $0 $0
Geoffrey Lamb (Board Member) $0 $0 $0
Adel Af Mahmoud (Board Member) $0 $0 $0
Purnima Mane (Board Member) $0 $0 $0
Majike Wijnroks (Board Member) $0 $0 $0
Helen Rees (Board Member) $0 $0 $0
Mary C Tydings (Board Member) $0 $0 $0
Alice Albright (Board Member (Until 3/15/13)) $0 $0 $0
Lord Fowler (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$61,459,050
Expenses
$69,073,411
Net Income
-$7,614,361
Net Assets
$68,529,213
Notable Sources of Revenue Percent of Total Revenue
Contributions $59,232,675
96.4%
Program Services $0
Investment Income $1,853,192
3.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $373,183
0.6%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,076,105
4.5%
Professional Fundraising Fees $0
Other Salaries and Wages $15,261,387
22.1%
Assets/Debt
Total Assets $90,186,843
Total Liabilities $21,657,630
Net Assets $68,529,213

Document Links

Fiscal Year Ending Dec.
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$60,597,835
Expenses
$79,059,033
Net Income
-$18,461,198
Net Assets
$76,333,601
Notable Sources of Revenue Percent of Total Revenue
Contributions $58,170,600
96.0%
Program Services $0
Investment Income $1,508,589
2.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $918,646
1.5%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,784,621
4.8%
Professional Fundraising Fees $0
Other Salaries and Wages $18,176,036
23.0%
Assets/Debt
Total Assets $99,007,459
Total Liabilities $22,673,858
Net Assets $76,333,601

Document Links

Fiscal Year Ending Dec.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2006

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2002

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2001

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »